Special article
Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

https://doi.org/10.1016/0002-9343(88)90310-5Get rights and content

Abstract

Existing methods for predicting creatinine clearance provide accurate estimates for normal-weight patients but not for patients who are obese. Studies into this problem began with an animal model of obesity, the obese overfed rat. Mean creatinine clearance was found to vary in direct proportion to fat-free body mass, determined in both obese and normal animals. The relevance of this observation to renal function in humans was evaluated by analyzing published studies reporting creatinine clearance and creatinine excretion rates in obese and normal persons. Measured creatinine clearance correlated well with estimated fat-free body mass (r = 0.772, p <0.02), and urinary excretion of creatinine normalized to fat-free mass correlated impressively with age (r = 0.960). Formulas derived from these observations allow for the prediction of creatinine clearance at steady state: Ccr (males) =[137 − Age] × (0.285 × Weight) + (12.1 × Height2)](51 × ScrCcr (females) =[146 − Age] × [(0.287 × Weight) + (9.74 × Height2)](60 × Scr In initial tests of these formulas, their predictions appeared to be as accurate as existing methods for the normal-weight population and far superior to these methods when applied to the obese population. Therefore, when creatinine clearance is not measured in obese patients, the estimation of this parameter with the proposed formulas should improve the ability to select the appropriate dose for drugs that are cleared principally by renal filtration.

References (36)

  • D.R. Abernethy et al.

    Drug disposition in obese humans—an update

    Clin Pharmacokinet

    (1986)
  • B.K. Wong et al.

    An overfed rat model that reproduces acetaminophen disposition in obese humans

    Drug Metab Dispos

    (1986)
  • N.J. Rothwell et al.

    In vivo determination of body composition by tritium dilution in the rat

    Br J Nutr

    (1979)
  • J.S. Garrow et al.

    Quetelet's index (W/H2) as a measure of fatness

    Int J Obes

    (1985)
  • J Kampmann et al.

    Rapid evaluation of creatinine clearance

    Acta Med Scand

    (1974)
  • D.W. Cockcroft et al.

    Prediction of creatinine clearance from serum creatinine

    Nephron

    (1976)
  • R.A. Blouin et al.

    Vancomycin pharmacokinetics in normal and morbidly obese subjects

    Antimicrob Agents Chemother

    (1982)
  • L.A. Bauer et al.

    Cimetidine clearance in the obese

    Clin Pharmacol Ther

    (1985)
  • Cited by (228)

    • Dose, dosage regimen, and dose adjustment in organ failure

      2021, Biopharmaceutics and Pharmacokinetics Considerations: Volume 1 in Advances in Pharmaceutical Product Development and Research
    • How do i manage the morbidly obese critically ill patient?

      2019, Evidence-Based Practice of Critical Care
    View all citing articles on Scopus

    This work was supported in part by Grant GM-20852 from the National Institutes of General Medical Sciences, National Institutes of Health.

    View full text